Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
The health digital twin to tackle cardiovascular disease—a review of an emerging interdisciplinary field
Potential benefits of precision medicine in cardiovascular disease (CVD) include more
accurate phenoty** of individual patients with the same condition or presentation, using …
accurate phenoty** of individual patients with the same condition or presentation, using …
[HTML][HTML] Mental stress and cardiovascular health—Part I
F Vancheri, G Longo, E Vancheri… - Journal of clinical medicine, 2022 - mdpi.com
Epidemiological studies have shown that a substantial proportion of acute coronary events
occur in individuals who lack the traditional high-risk cardiovascular (CV) profile. Mental …
occur in individuals who lack the traditional high-risk cardiovascular (CV) profile. Mental …
Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data
GA Figtree, ST Vernon, N Hadziosmanovic… - The Lancet, 2021 - thelancet.com
Background In cardiovascular disease, prevention strategies targeting standard modifiable
cardiovascular risk factors (SMuRFs; hypertension, diabetes, hypercholesterolaemia, and …
cardiovascular risk factors (SMuRFs; hypertension, diabetes, hypercholesterolaemia, and …
Higher mortality in acute coronary syndrome patients without standard modifiable risk factors: results from a global meta-analysis of 1,285,722 patients
Background Standard modifiable cardiovascular risk factors (SMuRF), comprising diabetes,
hyperlipidemia, hypertension, and smoking, are used for risk stratification in acute coronary …
hyperlipidemia, hypertension, and smoking, are used for risk stratification in acute coronary …
Genetic, sociodemographic, lifestyle, and clinical risk factors of recurrent coronary artery disease events: a population-based cohort study
Aims Complications of coronary artery disease (CAD) represent the leading cause of death
among adults globally. This study examined the associations and clinical utilities of genetic …
among adults globally. This study examined the associations and clinical utilities of genetic …
ST‐segment–elevation myocardial infarction (STEMI) patients without standard modifiable cardiovascular risk factors—how common are they, and what are their …
ST Vernon, S Coffey, M D'Souza, CK Chow… - Journal of the …, 2019 - ahajournals.org
Background Programs targeting the standard modifiable cardiovascular risk factors
(SMuRFs: hypertension, diabetes mellitus, hypercholesterolemia, smoking) are critical to …
(SMuRFs: hypertension, diabetes mellitus, hypercholesterolemia, smoking) are critical to …
Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art Review
GA Figtree, ST Vernon, JA Harmer, MP Gray… - Journal of the American …, 2023 - jacc.org
Reducing the incidence and prevalence of standard modifiable cardiovascular risk factors
(SMuRFs) is critical to tackling the global burden of coronary artery disease (CAD) …
(SMuRFs) is critical to tackling the global burden of coronary artery disease (CAD) …
Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiography
Clinical risk scores based on traditional risk factors of atherosclerosis correlate imprecisely
to an individual's complex pathophysiological predisposition to atherosclerosis and provide …
to an individual's complex pathophysiological predisposition to atherosclerosis and provide …
A call to action for new global approaches to cardiovascular disease drug solutions
GA Figtree, K Broadfoot, B Casadei, R Califf… - European heart …, 2021 - academic.oup.com
Whilst we continue to wrestle with the immense challenge of implementing equitable access
to established evidence-based treatments, substantial gaps remain in our pharmacotherapy …
to established evidence-based treatments, substantial gaps remain in our pharmacotherapy …
Noninvasive plaque imaging to accelerate coronary artery disease drug development
Coronary artery disease (CAD) remains the leading cause of adult mortality globally.
Targeting known modifiable risk factors has had substantial benefit, but there remains a …
Targeting known modifiable risk factors has had substantial benefit, but there remains a …